8 Points Inc. Announces Exclusive Agreement with Barberini Eyewear

8 Points Inc. and Barberini Eyewear announce their new North American eyewear collaboration. Barberini eyewear has signed a three-year agreement under which 8 Points Inc. will become the exclusive Canadian and American distributor for ophthalmic frames and sunglasses with platinum glass Barberini lenses.

Gianni Vetrini, the CEO of Barberini Eyewear speaks about his product: “[…] Our company has a long history of making quality glass lenses and we are known for that above all. […] We have developed polarized lenses, our top product, together with the in-house design and construction of the machinery required to make them. In addition to polarized lenses we also make photochromic lenses with the Hydrogen Firing technique, innovative coatings and lenses in special glass. […] At last eyewear that focuses totally on lenses, obviously without neglecting aesthetics and comfort.”

Fernando Silva, president of 8 points Inc., said: “We couldn’t be more excited to be the North American distributor for such an opulent eyewear collection. This company boasts organic and luxurious products as they own the entire production from mining the rare earth, refining their glass, and producing their lenses. All their factories are established across Europe where they’re lenses are renowned as the best in the world.”

This luxury eyewear collection will be available across Canada and the USA starting September 1st, 2017.

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more